Abstract
ABSTRACT
Background
Vitamin D modulates innate and adaptive immunity and has been investigated for preventing pediatric respiratory infections.
Objective
To assess the effects of vitamin D supplementation on respiratory tract infections (RTIs), including upper RTIs, lower RTIs/recurrent pneumonia, and hospitalization/clinical severity in children and adolescents.
Methods
Systematic review and random-effects meta-analysis of 16 publications, of which 13 contributed to quantitative synthesis. Twenty-four effect estimates were pooled, eight per outcome. The odds ratio (OR) was analyzed on its natural logarithmic scale (logOR), using restricted maximum likelihood (REML) estimation and Knapp-Hartung (KH) adjusted inference. Where necessary, risk ratios (RRs), hazard ratios (HRs), and incidence rate ratios (IRRs) were approximated on the logOR scale.
Results
For respiratory infection/upper RTI, pooled logOR was −0.284 (KH-adjusted 95% confidence interval [CI]: −0.678 to 0.110; OR 0.753; p = 0.132; I
2
= 97.2%). For lower RTI/recurrent pneumonia, logOR was −0.445 (95% CI: −0.987 to 0.097; OR 0.641; p = 0.093; I
2
= 89.5%). For hospitalization/clinical severity, logOR was −0.609 (95% CI: −1.134 to −0.083; OR 0.544; p = 0.029; I
2
= 78.3%).
Conclusions
Pooled estimates favored supplementation in direction for all three groups, although confidence intervals included the null for the first two. Heterogeneity was substantial, and the results are limited by approximations among effect measures, clinically diverse endpoints, and potentially correlated effects from individual studies.